Conference item : Abstract
Oral bisphosphonates and chronic kidney disease: progression and safety
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 16.6KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00198-018-4738-8
Authors
- Publisher:
- Springer
- Host title:
- Osteoporosis International
- Journal:
- OSTEOPOROSIS INTERNATIONAL More from this journal
- Volume:
- 29
- Issue:
- S2
- Pages:
- 601
- Publication date:
- 2018-11-07
- Acceptance date:
- 2018-08-03
- DOI:
- EISSN:
-
1433-2965
- ISSN:
-
0937-941X
- Subtype:
-
Abstract
- Pubs id:
-
pubs:950395
- UUID:
-
uuid:b79bbe36-cb2a-4256-9876-aa08bac6ff03
- Local pid:
-
pubs:950395
- Source identifiers:
-
950395
- Deposit date:
-
2019-01-07
Terms of use
- Copyright holder:
- International Osteoporosis Foundation and National Osteoporosis Foundation
- Copyright date:
- 2018
- Notes:
- © International Osteoporosis Foundation and National Osteoporosis Foundation 2018. This paper was presented at the Osteoporosis Conference 2018 Birmingham, UK 2 – 4 December 2018. This is the accepted manuscript version of the abstract. The final version is available online from Springer at: 10.1007/s00198-018-4738-8
If you are the owner of this record, you can report an update to it here: Report update to this record